Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NS-2359 advanced into phase II

March 31, 2005

Complement inhibitors for neurodegenerative, autoimmune disorders disclosed in recent patents

March 30, 2005

Rasagiline improves fluctuations in levodopa-treated Parkinson's disease patients

March 30, 2005

Anticonvulsants show promise in the management of impulsive aggression

March 30, 2005

Antiinflammatory and antiapoptotic properties of MX-1153

March 30, 2005

Cannabinoid CB1 antagonists active in advanced Parkinson's disease model

March 29, 2005

SGS-742 evaluated in new phase II study for adult ADHD

March 29, 2005

Patents covering treatments for pain disclosed

March 24, 2005

SR-142801 produces mixed results in panic disorder trial

March 24, 2005

Ropinirole demonstrates efficacy in restless legs syndrome

March 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...